Baillie Gifford: 7 Evolent Health transactions (Baillie Gifford & Co /

7 Baillie Gifford Evolent Health Trades

The first Evolent Health trade was made in Q2 2018. Since then Baillie Gifford bought shares four more times and sold shares on two occasions. The investor sold all their shares in Q4 2019 and doesn't own any shares in Evolent Health anymore.

Avg closing price

Price range

Sold -1.08M shares Q4 2019

Avg closing price $8.12

Price range $6.49 - $10.68

Increased shares by 1.1% (+11.6k shares) Q3 2019

Avg closing price $7.18

Price range $5.82 - $8.31

Sold 0.1% shares (-967 shares) Q2 2019

Avg closing price $11.84

Price range $7.71 - $14.54

Increased shares by 4.1% (+42.6k shares) Q1 2019

Avg closing price $15.83

Price range $12.17 - $20.92

Increased shares by 2.8% (+27.6k shares) Q4 2018

Avg closing price $23.13

Price range $17.75 - $27.20

Increased shares by 15.5% (+135k shares) Q3 2018

Avg closing price $23.85

Price range $20.10 - $28.75

New holding (+868k shares) Q2 2018

Avg closing price $18.93

Price range $13.80 - $23.95

Never miss a trade

早乙女迅雷

Baillie Gifford Evolent Health Inc - Ordinary Shares - Class A

Current Value of Holding

Shares

% of Portfolio

Average Buy Price

7 Baillie Gifford Evolent Health Trades

早乙女迅雷

Baillie Gifford Evolent Health Inc - Ordinary Shares - Class A

7 Baillie Gifford Evolent Health Trades

Embed chart